(Q45096240)

9 December 2017

1 reference

title

HTLV-1-associated myelopathy/tropical spastic paraparesis. (English)

1 reference

Human T-lymphotropic virus 1

9 December 2017

0 references

author

Charles Bangham

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Abelardo Araujo

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Yoshihisa Yamano

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Graham P Taylor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

18 June 2015

1 reference

Nature Reviews Disease Primers

9 December 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

15012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27188208%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrdp.2015.12

6 June 2020

exact match

0 references

cites work

Natural history of adult T-cell leukemia/lymphoma and approaches to therapy

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

A prospective study of transmission by transfusion of HTLV-I and risk factors associated with seroconversion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Transmission of human T-lymphotropic virus types I and II by blood transfusion. A retrospective study of recipients of blood components (1983 through 1988). The American Red Cross HTLV-I/II Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Quantification of HTLV-1 clonality and TCR diversity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

The host genomic environment of the provirus determines the abundance of HTLV-1-infected T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

CLINICAL AND PATHOLOGICAL OBSERVATIONS ON JAMAICAN NEUROPATHY; A REPORT ON 206 CASES

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-I associated myelopathy, a new clinical entity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Natural history of human T-lymphotropic virus 1-associated myelopathy: a 14-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Epidemiological Aspects and World Distribution of HTLV-1 Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

An HTLV-I vaccine: why, how, for whom?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Clinical associations of Human T-Lymphotropic Virus type 1 infection in an indigenous Australian population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Long-term follow up study of vertical HTLV-I infection in children breast-fed by seropositive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-associated myelopathy in a cohort of HTLV-I and HTLV-II-infected blood donors. The REDS investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Prevalence and clinical features of HTLV neurologic disease in the HTLV Outcomes Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Incidence of HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica and Trinidad

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

A cluster of HTLV-1 associated tropical spastic paraparesis in Equateur (Zaire): ethnic and familial distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Evaluation of adult T-cell leukemia/lymphoma incidence and its impact on non-Hodgkin lymphoma incidence in southwestern Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T cell leukemia virus type I infection and chronic myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Histopathological analysis of four autopsy cases of HTLV-I-associated myelopathy/tropical spastic paraparesis: inflammatory changes occur simultaneously in the entire central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Imaging of human T-lymphotropic virus type I-associated chronic progressive myeloneuropathies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Uveitis associated with human T lymphotropic virus type I: seroepidemiologic, clinical, and virologic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 and polymyositis in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotrophic virus type 1-associated infective dermatitis: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Chronic inflammatory arthropathy associated with HTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1-infected T cells contain a single integrated provirus in natural infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

CTL quality and the control of human retroviral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Prospective study of HTLV-I infection in an initially asymptomatic cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Subacute progression of human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

A 15-year prospective longitudinal study of disease progression in patients with HTLV-1 associated myelopathy in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Primate T-lymphotropic virus type I LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Phylogenetic subgroups of human T cell lymphotropic virus (HTLV) type I in the tax gene and their association with different risks for HTLV-I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HLA class I alleles in HTLV-1-associated myelopathy and asymptomatic carriers from the Brazilian cohort GIPH.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Association between HLA alleles and HAM/TSP in individuals infected with HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Correlation between polymorphisms at interleukin-6 but not at interleukin-10 promoter and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis in Brazilian individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

IL28B gene polymorphism SNP rs8099917 genotype GG is associated with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-1 carriers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Familial clusters of HTLV-1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-I-associated myelopathy following allogeneic bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-I-associated myelopathy associated with blood transfusion in the United States: epidemiologic and molecular evidence linking donor and recipient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

The roles of acquired and innate immunity in human T-cell leukemia virus type 1-mediated diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Systems biology approaches reveal a specific interferon-inducible signature in HTLV-1 associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Stromal cell-mediated suppression of human T-cell leukemia virus type 1 expression in vitro and in vivo by type I interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Cellular immune response to HTLV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T cell lymphotropic virus (HTLV) type-1-specific CD8+ T cells: frequency and immunodominance hierarchy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Predominant recognition of human T cell leukemia virus type I (HTLV-I) pX gene products by human CD8+ cytotoxic T cells directed against HTLV-I-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Quantifying HTLV-I dynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Population dynamics of immune responses to persistent viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HLA class I binding of HBZ determines outcome in HTLV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

KIR2DL2 enhances protective and detrimental HLA class I-mediated immunity in chronic viral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

High frequencies of Th1-type CD4(+) T cells specific to HTLV-1 Env and Tax proteins in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

High frequency of CD4+FoxP3+ cells in HTLV-1 infection: inverse correlation with HTLV-1-specific CTL response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotropic virus type 1-induced CC chemokine ligand 22 maintains a high frequency of functional FoxP3+ regulatory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-cell lymphotropic virus type I-associated adult T-cell leukemia-lymphoma: new directions in clinical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Tax-inducible production of CC chemokine ligand 22 by human T cell leukemia virus type 1 (HTLV-1)-infected T cells promotes preferential transmission of HTLV-1 to CCR4-expressing CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Cellular immune surveillance against HTLV-I infected T lymphocytes in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Low frequency of CD94/NKG2A+ T lymphocytes in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis, but not in asymptomatic carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Natural killer (NK) cells in HTLV-I-associated myelopathy/tropical spastic paraparesis-decrease in NK cell subset populations and activity in HTLV-I seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Virus markers associated with vertical transmission of human T lymphotropic virus type 1 in Jamaica

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Selection forces and constraints on retroviral sequence variation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Autoimmunity due to molecular mimicry as a cause of neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Significantly increased antibody response to heterogeneous nuclear ribonucleoproteins in cerebrospinal fluid of multiple sclerosis patients but not in patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 clonality in adult T-cell leukaemia and non-malignant HTLV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Do T cells cause HTLV-1-associated disease?: a taxing problem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and p

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Pre-morbid human T-lymphotropic virus type I proviral load, rather than percentage of abnormal lymphocytes, is associated with an increased risk of aggressive adult T-cell leukemia/lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Sensory dysfunction in HTLV-I-associated myelopathy/tropical spastic paraparesis. A comprehensive neurophysiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Prevalence of erectile dysfunction in HTLV-1-infected patients and its association with overactive bladder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

The HTLV-1 neurological complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Disability profile of patients with HTLV-I-associated myelopathy/tropical spastic paraparesis using the Functional Independence Measure (FIM).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Two Babinski signs in seropositive (HAM) and seronegative tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Diagnosis of HAM/TSP based on CSF proviral HTLV-I DNA and HTLV-I antibody index

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

CSF-chemokines in HTLV-I-associated myelopathy: CXCL10 up-regulation and therapeutic effect of interferon-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Levels of serum chemokines discriminate clinical myelopathy associated with human T lymphotropic virus type 1 (HTLV-1)/tropical spastic paraparesis (HAM/TSP) disease from HTLV-1 carrier state

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Plasma proteome analysis in HTLV-1-associated myelopathy/tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Chronic progressive cervical myelopathy with HTLV-I infection: Variant form of HAM/TSP?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Abnormalities of spinal magnetic resonance images implicate clinical variability in human T-cell lymphotropic virus type I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Incidence and clinical significances of human T-cell lymphotropic virus type I-associated myelopathy with T2 hyperintensity on spinal magnetic resonance images

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Persistence of HTLV-I in blood components after leukocyte depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Severe demyelinating myelopathy with low human T cell lymphotropic virus type 1 expression after transfusion in an immunosuppressed patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Clinical characteristics of patients in Peru with human T cell lymphotropic virus type 1-associated tropical spastic paraparesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Corticosteroid therapy in TSP/HAM patients: the results from a 10 years open cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Histone deacetylase mediated transcriptional activation reduces proviral loads in HTLV-1 associated myelopathy/tropical spastic paraparesis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Systemic interferon-alpha in the treatment of HTLV-I-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Long-term, high dose interferon-alpha treatment in HTLV-I-associated myelopathy/tropical spastic paraparesis: a combined clinical, virological and immunological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Ciclosporin A proof of concept study in patients with active, progressive HTLV-1 associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Treatment of patients with HTLV-1-associated myelopathy with methotrexate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Successful application of pentoxifylline in the treatment of HTLV-I associated myelopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Tropical Spastic Paraparesis/HTLV-1-Associated Myelopathy (TSP/HAM): Treatment with an Anabolic Steroid Danazol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Efficacy of prosultiamine treatment in patients with human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis: results from an open-label clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Pentosan polysulfate treatment ameliorates motor function with increased serum soluble vascular cell adhesion molecule-1 in HTLV-1-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotropic virus 1 neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Quality of life in patients with HTLV-I associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Implications of HAM/TSP functional incapacity in the quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Fatigue in multiple sclerosis: a look at the role of poor sleep

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Impact of HTLV-I in quality of life and urogynecologic parameters of women with urinary incontinence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Characteristics of Chronic Pain and Its Impact on Quality of Life of Patients With HTLV-1-associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Pain in tropical spastic paraparesis/HTLV-I associated myelopathy patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Stem cell therapy for the spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Neurogenesis and brain injury: managing a renewable resource for repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Overview on HTLV-1 p12, p8, p30, p13: accomplices in persistent infection and viral pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Mechanisms of HTLV-1 persistence and transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-cell leukemia virus type 1 (HTLV-1) and leukemic transformation: viral infectivity, Tax, HBZ and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-cell leukemia virus type 1: replication, proliferation and propagation by Tax and HTLV-1 bZIP factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Multiple viral strategies of HTLV-1 for dysregulation of cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-I basic leucine zipper factor gene mRNA supports proliferation of adult T cell leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Engagement of specific T-cell surface molecules regulates cytoskeletal polarization in HTLV-1-infected lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotropic virus, type 1, tax protein triggers microtubule reorientation in the virological synapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotropic virus-1 visualized at the virological synapse by electron tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

The mechanism of retroviral integration from X-ray structures of its key intermediates

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Low prevalence of flower cells in U.S.A. blood donors infected with human T-lymphotrophic virus types I and II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Safety and efficacy of interferon-alpha in 167 patients with human T-cell lymphotropic virus type 1-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Interferon-beta1a therapy in human T-lymphotropic virus type I-associated neurologic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Danazol a new perspective in the treatment of htlv-l associated myelopathy (preliminary report)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Intermittent high-dose vitamin C therapy in patients with HTLV-I associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Plasmapheresis in treatment of human T-lymphotropic virus type-I associated myelopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Detection of human T-lymphotropic virus type I (HTLV-I) tax RNA in the central nervous system of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by in situ hybridization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Safety of long-term treatment of HAM/TSP patients with valproic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-1 provirus load in peripheral blood lymphocytes of HTLV-1 carriers is diminished by green tea drinking

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Heparin treatment in patients with human T-lymphotropic virus type I (HTLV-I)-associated myelopathy: a preliminary study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Clinical pathophysiology of human T-lymphotropic virus-type 1-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Spasticity - Pathogenesis, prevention and treatment strategies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Symptom profiles differ in patients with neuropathic versus non-neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Pharmacological management of chronic neuropathic pain - consensus statement and guidelines from the Canadian Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Pharmacologic management of chronic low back pain: synthesis of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Proprioceptive neuromuscular facilitation in HTLV-I-associated myelopathy/tropical spastic paraparesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. I. Demographic determinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Incidence of human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in a long-term prospective cohort study of initially asymptomatic individuals in Brazil.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Human T cell lymphotropic virus type 1 viral load variability and long-term trends in asymptomatic carriers and in patients with human T cell lymphotropic virus type 1-related diseases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Virus-induced dysfunction of CD4+CD25+ T cells in patients with HTLV-I-associated neuroimmunological disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

HTLV-I-associated myelopathy: analysis of 213 patients based on clinical features and laboratory findings.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Abnormal peripheral lymphocytes in tropical spastic paraparesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

inferred from DOI database lookup

7 January 2021

based on heuristic

Sequence variants of human T-cell lymphotropic virus type I from patients with tropical spastic paraparesis and adult T-cell leukemia do not distinguish neurological from leukemic isolates

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12

inferred from DOI database lookup

7 January 2021

based on heuristic

Induction of antibody responses that neutralize human T-cell leukemia virus type I infection in vitro and in vivo by peptide immunization

1 reference

https://api.crossref.org/works/10.1038%2FNRDP.2015.12